Ignite Creation Date:
2024-05-06 @ 7:43 PM
Last Modification Date:
2025-12-16 @ 5:12 PM
Study NCT ID:
NCT06102759
Status:
None
Last Update Posted:
2023-10-26 00:00:00
First Post:
2023-10-22 00:00:00
Brief Title:
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed
Sponsor:
Organization:
Tianjin Medical University Cancer Institute and Hospital
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
30
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 100515 |
Who Masked List: